 | • レポートコード：D0GIR-01034 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腹膜がんの世界市場を広く調査・分析し、今後の市場展望をまとめております。腹膜がんの種類別市場規模（手術、化学療法（抗がん剤）、放射線療法（高エネルギー線））、用途別市場規模（がん研究センター、がん病院、外科センター、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、EntreMed、Millennium Pharmaceuticals、GlaxoSmithKline、Incyte、Oxford BioMedica、Synta Pharmaceuticals、Bayer、Novartis、Oncolytics Biotech、Oasmia Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・腹膜がんの北米市場（アメリカ、カナダ、メキシコ） ・腹膜がんのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腹膜がんのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腹膜がんの南米市場（ブラジル、アルゼンチン） ・腹膜がんの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：手術、化学療法（抗がん剤）、放射線療法（高エネルギー線） ・用途別分析：がん研究センター、がん病院、外科センター、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Peritoneal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Peritoneal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Peritoneal Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peritoneal Cancer market has been segmented into:
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
By Application, Peritoneal Cancer has been segmented into:
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peritoneal Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Peritoneal Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peritoneal Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Peritoneal Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Peritoneal Cancer Market Share Analysis
Peritoneal Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peritoneal Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peritoneal Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Peritoneal Cancer are:
AstraZeneca
EntreMed
Millennium Pharmaceuticals
GlaxoSmithKline
Incyte
Oxford BioMedica
Synta Pharmaceuticals
Bayer
Novartis
Oncolytics Biotech
Oasmia Pharmaceutical
Table of Contents
1 Peritoneal Cancer Market Overview
1.1 Product Overview and Scope of Peritoneal Cancer
1.2 Classification of Peritoneal Cancer by Type
1.2.1 Global Peritoneal Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Peritoneal Cancer Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Chemotherapy (Anticancer Drugs)
1.2.5 Radiotherapy (High-Energy Rays)
1.3 Global Peritoneal Cancer Market by Application
1.3.1 Overview: Global Peritoneal Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.4 Global Peritoneal Cancer Market by Regions
1.4.1 Global Peritoneal Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Peritoneal Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Peritoneal Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Peritoneal Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peritoneal Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Peritoneal Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peritoneal Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 EntreMed
2.2.1 EntreMed Details
2.2.2 EntreMed Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 EntreMed SWOT Analysis
2.2.4 EntreMed Product and Services
2.2.5 EntreMed Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Millennium Pharmaceuticals
2.3.1 Millennium Pharmaceuticals Details
2.3.2 Millennium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Millennium Pharmaceuticals SWOT Analysis
2.3.4 Millennium Pharmaceuticals Product and Services
2.3.5 Millennium Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 Incyte
2.5.1 Incyte Details
2.5.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Incyte SWOT Analysis
2.5.4 Incyte Product and Services
2.5.5 Incyte Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Oxford BioMedica
2.6.1 Oxford BioMedica Details
2.6.2 Oxford BioMedica Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Oxford BioMedica SWOT Analysis
2.6.4 Oxford BioMedica Product and Services
2.6.5 Oxford BioMedica Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Synta Pharmaceuticals
2.7.1 Synta Pharmaceuticals Details
2.7.2 Synta Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Synta Pharmaceuticals SWOT Analysis
2.7.4 Synta Pharmaceuticals Product and Services
2.7.5 Synta Pharmaceuticals Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.10 Oncolytics Biotech
2.10.1 Oncolytics Biotech Details
2.10.2 Oncolytics Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Oncolytics Biotech SWOT Analysis
2.10.4 Oncolytics Biotech Product and Services
2.10.5 Oncolytics Biotech Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.11 Oasmia Pharmaceutical
2.11.1 Oasmia Pharmaceutical Details
2.11.2 Oasmia Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Oasmia Pharmaceutical SWOT Analysis
2.11.4 Oasmia Pharmaceutical Product and Services
2.11.5 Oasmia Pharmaceutical Peritoneal Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Peritoneal Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Peritoneal Cancer Players Market Share
3.2.2 Top 10 Peritoneal Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Peritoneal Cancer Revenue and Market Share by Regions
4.2 North America Peritoneal Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Peritoneal Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Peritoneal Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Peritoneal Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Peritoneal Cancer Revenue and Growth Rate (2015-2020)
5 North America Peritoneal Cancer Revenue by Countries
5.1 North America Peritoneal Cancer Revenue by Countries (2015-2020)
5.2 USA Peritoneal Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Peritoneal Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Peritoneal Cancer Revenue and Growth Rate (2015-2020)
6 Europe Peritoneal Cancer Revenue by Countries
6.1 Europe Peritoneal Cancer Revenue by Countries (2015-2020)
6.2 Germany Peritoneal Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Peritoneal Cancer Revenue and Growth Rate (2015-2020)
6.4 France Peritoneal Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Peritoneal Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Peritoneal Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Peritoneal Cancer Revenue by Countries
7.1 Asia-Pacific Peritoneal Cancer Revenue by Countries (2015-2020)
7.2 China Peritoneal Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Peritoneal Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Peritoneal Cancer Revenue and Growth Rate (2015-2020)
7.5 India Peritoneal Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Peritoneal Cancer Revenue and Growth Rate (2015-2020)
8 South America Peritoneal Cancer Revenue by Countries
8.1 South America Peritoneal Cancer Revenue by Countries (2015-2020)
8.2 Brazil Peritoneal Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Peritoneal Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Peritoneal Cancer by Countries
9.1 Middle East & Africa Peritoneal Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Peritoneal Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Peritoneal Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Peritoneal Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Peritoneal Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Peritoneal Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Peritoneal Cancer Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Chemotherapy (Anticancer Drugs) Revenue Growth Rate (2015-2025)
10.5 Radiotherapy (High-Energy Rays) Revenue Growth Rate (2015-2025)
11 Global Peritoneal Cancer Market Segment by Application
11.1 Global Peritoneal Cancer Revenue Market Share by Application (2015-2020)
11.2 Peritoneal Cancer Market Forecast by Application (2019-2024)
11.3 Cancer Research Centers Revenue Growth (2015-2020)
11.4 Cancer Hospital Revenue Growth (2015-2020)
11.5 Surgical Centers Revenue Growth (2015-2020)
11.6 Clinics Revenue Growth (2015-2020)
12 Global Peritoneal Cancer Market Size Forecast (2021-2025)
12.1 Global Peritoneal Cancer Market Size Forecast (2021-2025)
12.2 Global Peritoneal Cancer Market Forecast by Regions (2021-2025)
12.3 North America Peritoneal Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Peritoneal Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Peritoneal Cancer Revenue Market Forecast (2021-2025)
12.6 South America Peritoneal Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Peritoneal Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Peritoneal Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peritoneal Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peritoneal Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Peritoneal Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Peritoneal Cancer Major Business
Table 7. AstraZeneca Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Peritoneal Cancer Product and Solutions
Table 10. AstraZeneca Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. EntreMed Corporate Information, Location and Competitors
Table 12. EntreMed Peritoneal Cancer Major Business
Table 13. EntreMed Peritoneal Cancer Total Revenue (USD Million) (2018-2019)
Table 14. EntreMed SWOT Analysis
Table 15. EntreMed Peritoneal Cancer Product and Solutions
Table 16. EntreMed Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Millennium Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Millennium Pharmaceuticals Peritoneal Cancer Major Business
Table 19. Millennium Pharmaceuticals Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Millennium Pharmaceuticals SWOT Analysis
Table 21. Millennium Pharmaceuticals Peritoneal Cancer Product and Solutions
Table 22. Millennium Pharmaceuticals Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Corporate Information, Location and Competitors
Table 24. GlaxoSmithKline Peritoneal Cancer Major Business
Table 25. GlaxoSmithKline Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline Peritoneal Cancer Product and Solutions
Table 28. GlaxoSmithKline Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Incyte Corporate Information, Location and Competitors
Table 30. Incyte Peritoneal Cancer Major Business
Table 31. Incyte Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 32. Incyte SWOT Analysis
Table 33. Incyte Peritoneal Cancer Product and Solutions
Table 34. Incyte Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Oxford BioMedica Corporate Information, Location and Competitors
Table 36. Oxford BioMedica Peritoneal Cancer Major Business
Table 37. Oxford BioMedica Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Oxford BioMedica SWOT Analysis
Table 39. Oxford BioMedica Peritoneal Cancer Product and Solutions
Table 40. Oxford BioMedica Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Synta Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Synta Pharmaceuticals Peritoneal Cancer Major Business
Table 43. Synta Pharmaceuticals Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Synta Pharmaceuticals SWOT Analysis
Table 45. Synta Pharmaceuticals Peritoneal Cancer Product and Solutions
Table 46. Synta Pharmaceuticals Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bayer Corporate Information, Location and Competitors
Table 48. Bayer Peritoneal Cancer Major Business
Table 49. Bayer Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Bayer SWOT Analysis
Table 51. Bayer Peritoneal Cancer Product and Solutions
Table 52. Bayer Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis Corporate Information, Location and Competitors
Table 54. Novartis Peritoneal Cancer Major Business
Table 55. Novartis Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Novartis SWOT Analysis
Table 57. Novartis Peritoneal Cancer Product and Solutions
Table 58. Novartis Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Oncolytics Biotech Corporate Information, Location and Competitors
Table 60. Oncolytics Biotech Peritoneal Cancer Major Business
Table 61. Oncolytics Biotech Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 62. Oncolytics Biotech SWOT Analysis
Table 63. Oncolytics Biotech Peritoneal Cancer Product and Solutions
Table 64. Oncolytics Biotech Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Oasmia Pharmaceutical Corporate Information, Location and Competitors
Table 66. Oasmia Pharmaceutical Peritoneal Cancer Major Business
Table 67. Oasmia Pharmaceutical Peritoneal Cancer Total Revenue (USD Million) (2017-2018)
Table 68. Oasmia Pharmaceutical SWOT Analysis
Table 69. Oasmia Pharmaceutical Peritoneal Cancer Product and Solutions
Table 70. Oasmia Pharmaceutical Peritoneal Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Peritoneal Cancer Revenue (Million USD) by Players (2015-2020)
Table 72. Global Peritoneal Cancer Revenue Share by Players (2015-2020)
Table 73. Global Peritoneal Cancer Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Peritoneal Cancer Revenue Market Share by Regions (2015-2020)
Table 75. North America Peritoneal Cancer Revenue by Countries (2015-2020)
Table 76. North America Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Table 77. Europe Peritoneal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Peritoneal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Peritoneal Cancer Revenue by Countries (2015-2020)
Table 80. South America Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Peritoneal Cancer Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Table 83. Global Peritoneal Cancer Revenue (Million USD) by Type (2015-2020)
Table 84. Global Peritoneal Cancer Revenue Share by Type (2015-2020)
Table 85. Global Peritoneal Cancer Revenue Forecast by Type (2021-2025)
Table 86. Global Peritoneal Cancer Revenue by Application (2015-2020)
Table 87. Global Peritoneal Cancer Revenue Share by Application (2015-2020)
Table 88. Global Peritoneal Cancer Revenue Forecast by Application (2021-2025)
Table 89. Global Peritoneal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Peritoneal Cancer Picture
Figure 2. Global Peritoneal Cancer Revenue Market Share by Type in 2019
Figure 3. Surgery Picture
Figure 4. Chemotherapy (Anticancer Drugs) Picture
Figure 5. Radiotherapy (High-Energy Rays) Picture
Figure 6. Peritoneal Cancer Revenue Market Share by Application in 2019
Figure 7. Cancer Research Centers Picture
Figure 8. Cancer Hospital Picture
Figure 9. Surgical Centers Picture
Figure 10. Clinics Picture
Figure 11. Global Peritoneal Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Peritoneal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Peritoneal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Peritoneal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Peritoneal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Peritoneal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Peritoneal Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Peritoneal Cancer Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Peritoneal Cancer Revenue Market Share in 2019
Figure 20. Global Top 10 Players Peritoneal Cancer Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Peritoneal Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Peritoneal Cancer Revenue Market Share by Regions (2015-2020)
Figure 24. Global Peritoneal Cancer Revenue Market Share by Regions in 2018
Figure 25. North America Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 26. Europe Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 28. South America Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 30. North America Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Figure 31. North America Peritoneal Cancer Revenue Market Share by Countries in 2019
Figure 32. USA Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 33. Canada Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 35. Europe Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Peritoneal Cancer Revenue Market Share by Countries in 2019
Figure 37. Germany Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 38. UK Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 39. France Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 40. Russia Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Italy Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Peritoneal Cancer Revenue Market Share by Countries in 2019
Figure 44. China Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 45. Japan Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 46. Korea Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 47. India Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 49. South America Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Figure 50. South America Peritoneal Cancer Revenue Market Share by Countries in 2019
Figure 51. Brazil Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Peritoneal Cancer Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Peritoneal Cancer Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 56. UAE Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Peritoneal Cancer Revenue and Growth Rate (2015-2020)
Figure 59. Global Peritoneal Cancer Revenue Share by Type (2015-2020)
Figure 60. Global Peritoneal Cancer Revenue Share by Type in 2019
Figure 61. Global Peritoneal Cancer Market Share Forecast by Type (2021-2025)
Figure 62. Global Surgery Revenue Growth Rate (2015-2020)
Figure 63. Global Chemotherapy (Anticancer Drugs) Revenue Growth Rate (2015-2020)
Figure 64. Global Radiotherapy (High-Energy Rays) Revenue Growth Rate (2015-2020)
Figure 65. Global Peritoneal Cancer Revenue Share by Application (2015-2020)
Figure 66. Global Peritoneal Cancer Revenue Share by Application in 2019
Figure 67. Global Peritoneal Cancer Market Share Forecast by Application (2021-2025)
Figure 68. Global Cancer Research Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Cancer Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Surgical Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Clinics Revenue Growth Rate (2015-2020)
Figure 72. Global Peritoneal Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Peritoneal Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Peritoneal Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Peritoneal Cancer Revenue Market Forecast (2021-2025)
Figure 76. Europe Peritoneal Cancer Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Peritoneal Cancer Revenue Market Forecast (2021-2025)
Figure 78. South America Peritoneal Cancer Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Peritoneal Cancer Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
頭頸部がん治療薬/治療剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …- 上咽頭がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nasopharyngeal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nasopharyngeal Cancer m…
- 胃がん・胃がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Stomach Cancer and Gastric Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 前立腺がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Canc…
- 非血液がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Hematological Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Hemato…